Oramed Pharmaceuticals Inc.
- ORMP
- NASDAQ
- Biotechnology
- Oral Drug Delivery
- Diabetes Therapeutics
$4.07
Today −2.63%Quote Oct 16, 2026, 08:00 PM UTC
−12.85%over the last month
Max drawdown −15.0%From 1-month high −15.0%3 months −0.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$169.3M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$3.92
3.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ORMPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
13
Founded
2002